Nanode Therapeutics, Inc.

Bristol, RI Doing business as Nanode Therapeutics Inc.

UEI
DQ61FFMB5H28
CAGE
7HP22
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Asian-Pacific American Owned
  • Minority Owned Business
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
505 Clarks Row, Bristol, RI 02809, USA
Website
nanodetherapeutics.com
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Nanode Therapeutics, Inc.'s 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Developing a novel non-viral nanopieces gene delivery system for ad gene therapy Contract · 75N95022C00029 National Institute on Drug Abuse $441,150
Developing nanopieces, a platform rnai delivery technology for treatment of multiple diseases Grant · R41TR002298 National Center for Advancing Translational Sciences $285,808

Quick answers

What is Nanode Therapeutics, Inc.'s UEI?

Nanode Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is DQ61FFMB5H28.

What is Nanode Therapeutics, Inc.'s CAGE code?

Nanode Therapeutics, Inc.'s CAGE code is 7HP22.

What is Nanode Therapeutics, Inc.'s primary NAICS code?

Nanode Therapeutics, Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).

Where is Nanode Therapeutics, Inc. located?

Nanode Therapeutics, Inc.'s physical address in SAM.gov is 505 Clarks Row, Bristol, RI 02809, USA.

Is Nanode Therapeutics, Inc. registered in SAM.gov?

Yes. Nanode Therapeutics, Inc.'s SAM.gov registration is active through August 20, 2027.

What is Nanode Therapeutics, Inc.'s most recent federal award?

Nanode Therapeutics, Inc.'s most recent federal contract award is Developing a novel non-viral nanopieces gene delivery system for ad gene therapy (75N95022C00029), from National Institute on Drug Abuse, on September 30, 2022.

On GovTribe

See Nanode Therapeutics, Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login